News and Trends 26 Oct 2016 Proteins can now Sing about their Anomalies to help cure Diseases Researchers are generating melodies from proteins’ structures. It could be used to understand protein folding and anomalies that contribute to disease. Protein folding is an infamously difficult phenomenon to understand and predict from sequence data. A collaboration between a resident composer at the University of Tempere in Finland and a scientist at the Francis Crick […] October 26, 2016 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2016 The Colours of Biotech: Who’s Doing What in the European Ecosystem in an Infographic Happy Monday! Our colleague, Justine, has put together a wonderful infographic to map out which European biotech companies are making moves in which field, from health to agrotech to medtech. Its vivid colours will surely brighten your day – take a look-see below! Justine is pursuing a PhD at the Heinrich Heine Universität in Düsseldorf after obtaining […] October 24, 2016 - 1 minutemin - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 18 Oct 2016 Shire’s leading Pancreatic Cancer drug is Back with a Bang Pancreatic cancer is one of the nastiest kinds and most difficult to treat; the EMA has granted marketing authorization to Onivyde in the fight against it. Pancreatic cancer is the fourth-leading cause of death in Europe, and it represents a dramatically underserved need. Metastatic adenocarcinoma is almost always fatal, as it cannot be removed surgically […] October 18, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2016 TxCell lines up another duck in its CAR-Treg campaign Novartis veteran Li Zhou has joined TxCell as the VP of cell engineering to oversee CAR-Treg programs for autoimmune and inflammation diseases. The French Treg maverick, TxCell, has hoovered up more talent to pioneer its hybrid CAR-Treg therapies: Li Zhou will be the new Vice President of the company’s cell engineering division. What we are doing here with CAR-Tregs to treat […] October 17, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2016 It’s not over yet for Opdivo; AbbVie takes a stand in Leukemia The Committee on Medicinal Products for Human Use (CHMP) has handed down a pair of positive opinions of Opdivo and AbbVie’s leukemia therapy in their quests for EMA approval. Before the European Commission reviews an application for market authorization, it crosses the collective desk of the Committee on Medicinal Products for Human Use (CHMP). If […] October 17, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 15 Oct 2016 This Scientist crystallises Bacteria for Stained Glass and Lace! Simon Park is a scientist who wants to teach us about the microbiome through his art. Among his works are a self-portrait, lace and stained glass, all of which have been produced from bacteria! At Cafe Science, Dr. Simon Park, Senior Lecturer in Microbial Sciences at the University of Surrey, described the diversity and ubiquity […] October 15, 2016 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 14 Oct 2016 This Biotech makes DNA Vaccines and Gene Therapy Possible in Lapland After Grenoble, we fly north to Finland to meet Santa’s reindeer and earn his good graces before Christmas. After a trip to the sauna and down time with Angry Birds, whose creator hails from the country, we moseyed over to visit FIT Biotech, our biotech of the week. City: Tampere, Finland Founded: 1995 Employees: 12 + […] October 14, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 13 Oct 2016 Adaptimmune Revises TCR Protocol following Phase I/IIa Failure Shares of Adaptimmune slid 12% yesterday morning after the company updated its TCR therapy to include fludarabine, which was linked to deaths in Juno’s CAR-T trials. Despite optimism that T-cells are the key to cancer cures, the field has taken a number of hits this year. Most recently, the FDA put a partial hold on […] October 13, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 11 Oct 2016 UK Upstart to sign Huge Deal with Takeda in End Run around Antibody Therapies Crescendo Biologics, a small UK-based startup, has made an almost €1B deal with Japanese giant Takeda for its Humabody technology. Crescendo Biologics may seem like a small fish, but it has caught the attention of a host of blue-chip investors like Sofinnova Partners. Its Humabody platform has recently attracted the Japanese pharmaceutical giant, Takeda, whose subsidiary, […] October 11, 2016 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 10 Oct 2016 Big Pharmas Battle to be the Lung Cancer Leader at ESMO Merck, Roche and BMS have unveiled updated results in Copenhagen as the companies duke it out for the leadership in lung cancer therapies. The conference of the European Society of Medical Oncology (ESMO) is underway in Copenhagen, and big pharma’s efforts to cure lung cancer are stealing the show. Three titans, Roche (Genentech), Merck and […] October 10, 2016 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 10 Oct 2016 Overseas Deaths in the Clinic come as a Blow to Boehringer Ingelheim Boehringer Ingelheim has swiftly dumped its olmutinib collaboration with Hanmi following news of deaths in South Korean Phase II trials. An investigation by the South Korean Ministry of Food and Drug Safety has linked several deaths to olmutinib, a lung cancer drug launched by Hanmi. Sound familiar? Boehringer Ingelheim just signed a deal to acquire the […] October 10, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2016 Do we hear a Tinnitus Cure? This techno-loving CEO might have one… It’s Friday, and here in Berlin, we’re ready for the club. A German company, Sonormed, is developing an app that can reduce the consequent ringing in our ears. Sonormed’s co-founder and CEO, Jörg Land, loves techno, and he started a company to help his fellow beat lovers with their common affliction of tinnitus. His soon-to-be […] October 7, 2016 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email